Ketoconazole (systemic) vs Brentuximab Vedotin

Interacting Drugs
Ketoconazole (systemic)
vs
Brentuximab Vedotin
Security Level
Minor, Monitor Therapy
Mechanism
Brentuximab Vedotin: CYP3A4 Inhibitors (Strong) may increase the serum concentration of Brentuximab Vedotin. Specifically, concentrations of the active monomethyl auristatin E (MMAE) component may be increased.
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Ketoconazole (systemic) vs Brentuximab Vedotin


Other Interactions of Ketoconazole (systemic)

We are Developing Our database, More results coming soon.

Other Interactions of Brentuximab Vedotin

We are Developing Our database, More results coming soon.